1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. California >
  6. Armata Pharmaceuticals Acquires C3J Therapeutics

M&A Deal Summary

Armata Pharmaceuticals Acquires C3J Therapeutics

On January 4, 2019, Armata Pharmaceuticals acquired life science company C3J Therapeutics

Acquisition Highlights
  • This is Armata Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Armata Pharmaceuticals’ 1st transaction in the United States.
  • This is Armata Pharmaceuticals’ 1st transaction in California.

M&A Deal Summary
Date 2019-01-04
Target C3J Therapeutics
Sector Life Science
Buyer(s) Armata Pharmaceuticals
Deal Type Merger
Advisor(s) Thompson Hine (Legal)

Target

C3J Therapeutics

Marina del Rey, California, United States
C3J Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving human health through the development of novel targeted antimicrobials that treat infectious diseases and address microbial dysbiosis associated with human disease. C3J Therapeutics is based in Marina del Rey, California.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Armata Pharmaceuticals

Marina del Rey, California, United States
Category Company
Founded 1989
Sector Life Science
Employees60
Revenue 42M USD (2024)
DESCRIPTION

Armata Pharmaceuticals is a biopharmaceutical company focused on the development of an internally generated pipeline of naturally occurring viruses called bacteriophage (phage) for the treatment of bacterial infection. Armata Pharmaceuticals was founded in 1989 and is based in Marina del Rey, California.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Merger M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-08 Novolytics - Bacteriophage Assets

United Kingdom

Novolytics - Bacteriophage Assets are naturally occurring viruses that are highly specific for the bacterial hosts they infect.

Buy -
Mergr

Solution for

Product

Company

Legal